Clinical Laboratory Testing Volume 2: Business Strategies

Questions: Discounts, Updates etc.

Pages: 98

Price: $1999

Publication Date: 2009-04-02

Order Online Now

People that purchased this report also purchased:

Contact LeadDiscovery

  • If you have questions about this report
  • To find out if you qualify for a discount
  • Want a more up to date version
  • Can't find a report that meets your needs
Search all reports

Keywords:

Boolean terms AND, OR, NOT can be used. Phrases should be entered within quotes. For wildcards use an *

Clinical laboratory testing is generally categorized as either of two general areas--clinical testing and anatomical pathology testing. Clinical and anatomical pathology procedures are frequently ordered as part of regular physician office visits and hospital admissions in connection with the diagnosis and treatment of illnesses. As such, clinical laboratory analysis is one of the most important sections of medical care.

The purpose of this report is to describe the specific segments of the clinical laboratory analysis business. The emphasis in this review is on those companies that are actively developing and marketing laboratory data for the clinical setting, including hospitals, independent labs, physician\'s offices and miscellaneous clinics. This study concentrates on the clinical laboratory industry in the U.S. It defines the dollar volume of sales in each major market and analyzes the factors that influence the size and the growth of the individual market segments. The study surveys some of the primary companies known to be marketing clinical laboratory data into the market. Each company is discussed in depth with a section on the history of the company, the product line, business and marketing analysis, and a subjective commentary of the position of the company in its market.

The report attempts to answer the questions:

This examination reviews the market for clinical laboratory data used in clinical practice. It defines the dollar volume of sales in each major market and analyzes the factors that influence the size and the growth of the individual market segments. The report details market sizes and growth rates for the U.S. and world markets. The study surveys some of the primary companies known to be marketing clinical laboratory data into the market. Each company is discussed in depth with a section on the history of the company, the product line, business and marketing analysis, and a subjective commentary of the position of the company in its market.

Unique benefits of this report are:

Table of Contents

 

  • LIST OF FIGURES

  • Figure 2.1:Total Medicare Expenditures, 1995-200812
  • Figure 2.2:Effect of Medicare Laboratory Fee Schedule Changes on a $10 Test, 1984-200613
  • Figure 2.3:Part B Spending on Clinical Laboratory Services, 1991-200714
  • Figure 2.4:Cost Per Billable Test16
  • Figure 2.5:Annual Billable Tests Processed Per FTE17
  • Figure 2.6:Outreach Business Operated at a Freestanding Lab Facility18
  • Figure 2.7:Volume of Dedicated Sales and Marketing Staff for Outreach Business18
  • Figure 2.8:Separately Managed Outreach Billing and Collection19
  • Figure 3.1:Lab Revenue by Lab Type22
  • Figure 3.2:Lab Revenue by Test Type22
  • Figure 3.3:Physician Office Laboratory Revenue, 2000-200625
  • Figure 3.4:Unweighted Average Medicare Reimbursement for the 10 Most Common POL Tests26
  • Figure 3.5:Total Number of Non-Waived POLs, 2000-200626
  • Figure 3.6:Number of New Tests Granted CLIA-Waived Status, 2000-200827
  • Figure 3.7:High-Volume Waived Tests28
  • Figure 4.1:U.S. Molecular Diagnostics Market Average Reimbursement Rate, 200941
  • Figure 4.2:Laboratory Service Revenue from Pap Testing, 1998-200546
  • Figure 4.3:Percentage of Pap Tests Performed Using Mono-Layer Methods, 1998-200646
  • Figure 4.4:Market Share for Pap Test Vendors, 200647
  • Figure 5.1:Percentage of Physicians in Practices with IT for Specific Clinical Activities55
  • Figure 6.1:Average Revenue Multiple Paid to Acquire Labs, 2000-200658
  • Figure 6.2: Value of Laboratory Mergers, Acquisitions, and IPO\'s 2004-200861
  • Figure 6.3:Hospital Market Share for Outreach Programs72


  • LIST OF TABLES

  • Table 2.1:Medicare Spending on Clinical Lab Services, 1991-200714
  • Table 2.2:Allowed Charges for Top 25 Clinical Laboratory Procedures, 200915
  • Table 2.3:Washington G-2 Hospital Lab Outreach Survey19
  • Table 3.1:U.S. Clinical Laboratory Testing Market Revenue, 2005-201221
  • Table 3.2:U.S. Clinical Laboratory Diagnostic Test Market Segments, 200821
  • Table 3.3:Growth Rates of Test Types23
  • Table 3.4:Independent Commercial Laboratory Testing Test Volume, 2005-201224
  • Table 3.5:Twenty Most Common Laboratory Tests Offered at Family Physician Offices29
  • Table 3.6:Important New Waived Tests29
  • Table 3.7:Revenue and at Leading Publicly-Traded Lab Companies, 200830
  • Table 3.8:Payer Group wise Percentage of Total Volume of Requisitions and Net Revenues33
  • Table 4.1:Pap Testing at the Largest U.S. Laboratory Companies, 200647
  • Table 5.1:Applications for Wireless LAN Technology53
  • Table 6.1:Laboratory/Pathology Acquisitions59
  • Table 6.2:Revenue Growth at Quest Diagnostics, 2000-200869
  • Table 6.3:Revenue Growth at LabCorp, 2000-200869
  • Table 6.4:LabCorp Revenue from Managed Care Contracts, 2004-200670
  • Table 6.5:Quest Diagnostics Revenue from Managed Care Contracts, 2004-200670
  • Table 7.1:Recent Acquisitions by Sonic Healthcare90
  • Table 8.1:Medicare Billing Guidelines for Multi-channel Laboratory Tests94
  • Table 8.2:U.S. POCT Market, 2000-201296
  • Table 8.3:U.S. POCT by Performance Location, 200896
  • Table 8.4:Targeted Lab Tests and Brief Educational Reminder Messages97
  •  

    Other users found this report page using the following search terms: Clinical Laboratory Testing in vitro diagnostics diagnostics POC immunoanalyzer Immunochemistry Immunoassay laboratory clinical lab testing tests business test market hospital diagnostic

    If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.


    Refund and Cancellation Policy: The descriptions of the products and services sold on LeadDiscovery.co.uk are as complete and accurate as possible, and customers are encouraged to read all available information about a product before placing an order. Due to the nature of the information being sold, orders for reports cannot be canceled.